Seoul Pharma Co. Ltd (018680) — Cash Flow Quality Index
Seoul Pharma Co. Ltd (018680) has a Cash Flow Quality Index of -1.01x as of September 2025. Operating cash flow of ₩-2.66 Billion is below net income of ₩2.62 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Seoul Pharma Co. Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Seoul Pharma Co. Ltd Cash Flow Quality Index (2008–2024)
Historical Cash Flow Quality Index for Seoul Pharma Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 018680 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Seoul Pharma Co. Ltd (2008–2024)
Year-by-year earnings quality comparison for Seoul Pharma Co. Ltd. For live market cap and the full company financial profile, see how much is Seoul Pharma Co. Ltd worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.77x | ₩-3.01 Billion | ₩1.70 Billion | ▼ -218.3% |
| 2023 | 1.50x | ₩5.26 Billion | ₩3.52 Billion | ▲ +1736.4% |
| 2022 | -0.09x | ₩-78.21 Million | ₩855.09 Million | ▼ -100.7% |
| 2019 | 12.40x | ₩2.93 Billion | ₩236.21 Million | ▲ +1060.9% |
| 2017 | -1.29x | ₩-1.14 Billion | ₩881.45 Million | ▲ +44.2% |
| 2016 | -2.31x | ₩-1.89 Billion | ₩816.80 Million | ▼ -236.5% |
| 2013 | -0.69x | ₩-425.00 Million | ₩618.00 Million | ▼ -138.1% |
| 2012 | 1.81x | ₩9.22 Billion | ₩5.10 Billion | ▼ -50.4% |
| 2011 | 3.64x | ₩4.86 Billion | ₩1.33 Billion | ▲ +248.5% |
| 2009 | 1.05x | ₩1.23 Billion | ₩1.18 Billion | ▲ +175.0% |
| 2008 | -1.39x | ₩-755.68 Million | ₩542.04 Million | — |